Rallybio to Present at Upcoming Investor Conferences in November
November 08 2023 - 8:00AM
Business Wire
Rallybio Corporation (Nasdaq: RLYB), a clinical-stage
biotechnology company committed to identifying and accelerating the
development of life-transforming therapies for patients with severe
and rare diseases, today announced its participation in the
following upcoming investor conferences:
- Stifel 2023 Healthcare Conference in New York, NY on
Wednesday, November 15, 2023. Steve Uden, M.D., Chief Executive
Officer will present a corporate overview at 3:00 p.m. EST.
- 6th Annual Evercore ISI HealthCONx Conference in Miami,
FL on Tuesday, November 28, 2023. Steve Uden. M.D., Chief Executive
Officer will participate in a fireside chat at 7:30 a.m. EST.
Live webcasts of both presentations will be accessible through
the Events and Presentations section of Rallybio’s website at
www.rallybio.com. A replay of the webcasts will be available for 30
days following each presentation.
About Rallybio
Rallybio (NASDAQ: RLYB) is a clinical-stage biotechnology
company with a mission to develop and commercialize
life-transforming therapies for patients with severe and rare
diseases. Rallybio has built a broad pipeline of promising product
candidates aimed at addressing diseases with unmet medical need in
areas of maternal fetal health, complement dysregulation,
hematology, and metabolic disorders. The Company has two clinical
stage programs: RLYB212, an anti-HPA-1a antibody for the prevention
of fetal and neonatal alloimmune thrombocytopenia (FNAIT) and
RLYB116, an inhibitor of complement component 5 (C5), with the
potential to treat several diseases of complement dysregulation, as
well as additional programs in preclinical development.
Rallybio is headquartered in New Haven, Connecticut with an
additional facility at the University of Connecticut’s Technology
Incubation Program in Farmington, Connecticut. For more
information, please visit www.rallybio.com and follow us on
LinkedIn and Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231028440323/en/
Investor Contacts Ami Bavishi Head of Investor Relations
and Communications 475-47-RALLY (Ext. 282)
abavishi@rallybio.com
Hannah Deresiewicz Stern Investor Relations, Inc. 212-362-1200
hannah.deresiewicz@sternir.com
Media Contact Jorge Gaeta Mission North (516) 430-7659
Rallybio@missionnorth.com
Rallybio (NASDAQ:RLYB)
Historical Stock Chart
From Apr 2024 to May 2024
Rallybio (NASDAQ:RLYB)
Historical Stock Chart
From May 2023 to May 2024